Skip to search formSkip to main contentSkip to account menu

Angiotensin-Converting Enzyme Inhibitors

Known as: Angiotensin Converting Enzyme Antagonists, Angiotensin I-Converting Enzyme Inhibitors, Inhibitors, Angiotensin-Converting Enzyme 
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting… 
National Institutes of Health

Related topics

Related topics

46 relations
Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme Inhibitors [MoA]Antihypertensive AgentsIn Blood
Expand

Narrower (37)

Benazepril hydrochloride 20 MG Oral TabletCaptoprilCaptopril / HydrochlorothiazideCilazapril
Expand

Broader (1)

Protease Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Highly Cited
2005
Highly Cited
2005
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
Background—Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by… 
Highly Cited
2003
Highly Cited
2003
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure… 
Highly Cited
2003
Highly Cited
2003
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on… 
Highly Cited
2002
Highly Cited
2002
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to…
CONTEXT Antihypertensive therapy is well established to reduce hypertension-related morbidity and mortality, but the optimal… 
Highly Cited
2000
Highly Cited
2000
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
BACKGROUND Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dysfunction, whether… 
Highly Cited
2000
Highly Cited
2000
A Human Homolog of Angiotensin-converting Enzyme
A novel human zinc metalloprotease that has considerable homology to human angiotensin-converting enzyme (ACE) (40% identity and… 
Review
1998
Review
1998
Angiotensin-converting enzyme inhibitors.
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and renal disease. ACE inhibitors alter the… 
Highly Cited
1996
Highly Cited
1996
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
Background Drugs that inhibit angiotensin-converting enzyme slow the progression of renal insufficiency in patients with diabetic… 
Review
1995
Review
1995
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Objective. —To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on mortality and morbidity in patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License